A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
THE PRESENT STATE AND FUTURE OF ORGAN PRESERVATION THERAPY FOR LARYNGEAL CARCINOMA(FROM THE RADIOTHERAPY STANDPOINT)
喉頭癌の機能温存療法の現状と将来―放射線治療の立場から―
2001
Japanese jornal of Head and Neck Cancer
喉頭癌の機能温存療法の現状と将来―放射線治療の立場から―
To improve the results of radiotherapy for laryngeal cancers, (1) altered fractionation schedules, such as hyperf ractionation or accelerated hyperf ractionation, and (2) combined chemotherapy, have recently been used. In our institution, a hyperfractionated and accelerated radiotherapy without a split was performed, to improve the local control probability for early glottic carcinomas. The accelerated fractionation program (AF) consisted of 1.72 Gy per fraction, two fractions per day, 5 days a
doi:10.5981/jjhnc1974.27.635
fatcat:dabv36ljj5cvtownfzzopkjtom